Dieser Download kann aus rechtlichen Gründen nur mit Rechnungsadresse in A, B, BG, CY, CZ, D, DK, EW, E, FIN, F, GR, HR, H, IRL, I, LT, L, LR, M, NL, PL, P, R, S, SLO, SK ausgeliefert werden.
Die Herstellerinformationen sind derzeit nicht verfügbar.
Inhaltsangabe
Section I: Molecular Biology, Biochemistry, Physiology, and Pharmacology of the Plasminogen-Plasmin Enzyme System.- 1 The Fibrinolytic System and Thrombolytic Agents.- 2 Plasminogen and Streptokinase.- 3 Tissue-type Plasminogen Activator (tPA).- 4 Urinary-type Plasminogen Activator (uPA).- 5 The Inhibitors of the Fibrinolytic System.- 6 Assembly of the Plasminogen System on Cell Surfaces.- Section II: Clinical Use of Thrombolytic Agents.- In Acute Myocardial Infarction.- 7 Streptokinase and Anisoylated Lys-Plasminogen Streptokinase Activator Complex.- 8 Tissue-Type Plasminogen Activator (tPA).- 9 Urokinase and Single-Chain Urokinase-Type Plasminogen Activator (Pro-urokinase).- 10 Comparative Evaluations of tPA vs SK with Particular Reference to the GUSTO-I Trial.- 11 Conjunctive Therapy to Reduce the Occurrence of Coronary Reocclusion After Thrombolytic Treatment of AMI.- Thrombolytic Treatment of other Clinical Thromboembolic Conditions.- 12 New Concepts in Thrombolysis of Pulmonary Embolism.- 13 Deep Venous Thrombosis.- 14 Peripheral Arterial Occlusions.- 15 Thrombotic Cerebrovascular Disease.- Thrombolytic Agents in Development, Biochemistry, Pharmacology - Efficacy in Animal Experiments and First Clinical Trials.- 16 Staphylokinase.- 17 Desmodus rotundus (Common Vampire Bat) Salivary Plasminogen Activator.- 18 Thrombus-Targeting of Plasminogen Activators.- 19 The Hunt for the Ideal Thrombolytic Agent: Mutants of tPA and uPA, Chimera of Both Molecules, Fibrolase.- 20 Agents which Increase Synthesis and Release of Tissue-Type Plasminogen Activator.- Autifibrinolytic Agents.- 21 Structure, Pharmacology, and Clinical Use of Antifibrinolytic Agents.
Section I: Molecular Biology, Biochemistry, Physiology, and Pharmacology of the Plasminogen-Plasmin Enzyme System.- 1 The Fibrinolytic System and Thrombolytic Agents.- 2 Plasminogen and Streptokinase.- 3 Tissue-type Plasminogen Activator (tPA).- 4 Urinary-type Plasminogen Activator (uPA).- 5 The Inhibitors of the Fibrinolytic System.- 6 Assembly of the Plasminogen System on Cell Surfaces.- Section II: Clinical Use of Thrombolytic Agents.- In Acute Myocardial Infarction.- 7 Streptokinase and Anisoylated Lys-Plasminogen Streptokinase Activator Complex.- 8 Tissue-Type Plasminogen Activator (tPA).- 9 Urokinase and Single-Chain Urokinase-Type Plasminogen Activator (Pro-urokinase).- 10 Comparative Evaluations of tPA vs SK with Particular Reference to the GUSTO-I Trial.- 11 Conjunctive Therapy to Reduce the Occurrence of Coronary Reocclusion After Thrombolytic Treatment of AMI.- Thrombolytic Treatment of other Clinical Thromboembolic Conditions.- 12 New Concepts in Thrombolysis of Pulmonary Embolism.- 13 Deep Venous Thrombosis.- 14 Peripheral Arterial Occlusions.- 15 Thrombotic Cerebrovascular Disease.- Thrombolytic Agents in Development, Biochemistry, Pharmacology - Efficacy in Animal Experiments and First Clinical Trials.- 16 Staphylokinase.- 17 Desmodus rotundus (Common Vampire Bat) Salivary Plasminogen Activator.- 18 Thrombus-Targeting of Plasminogen Activators.- 19 The Hunt for the Ideal Thrombolytic Agent: Mutants of tPA and uPA, Chimera of Both Molecules, Fibrolase.- 20 Agents which Increase Synthesis and Release of Tissue-Type Plasminogen Activator.- Autifibrinolytic Agents.- 21 Structure, Pharmacology, and Clinical Use of Antifibrinolytic Agents.
Es gelten unsere Allgemeinen Geschäftsbedingungen: www.buecher.de/agb
Impressum
www.buecher.de ist ein Internetauftritt der buecher.de internetstores GmbH
Geschäftsführung: Monica Sawhney | Roland Kölbl | Günter Hilger
Sitz der Gesellschaft: Batheyer Straße 115 - 117, 58099 Hagen
Postanschrift: Bürgermeister-Wegele-Str. 12, 86167 Augsburg
Amtsgericht Hagen HRB 13257
Steuernummer: 321/5800/1497
USt-IdNr: DE450055826
